Literature DB >> 7704377

Staphylococcus aureus: a review of the literature.

D Gould, A Chamberlaine.   

Abstract

Staphylococcus aureus has a long association with nosocomial infection. Problems date from the 1950s, although methicillin-resistant Staphylococcus aureus (MRSA) did not emerge until the following decade. Initially the pathogenicity of antibiotic-resistant strains was underestimated, and is still sometimes questioned, but today most authorities consider MRSA a serious threat, especially given current preoccupation with cost-effectiveness within the health service: nosocomial infection is associated with increased expenditure and may be regarded as a hallmark of indifferent nursing and medical care. This review documents the emergence of MRSA and recognition of the ensuing problems throughout the 1980s and early 1990s, with suggestions for nursing activities which could contribute towards improved control. Lessons learnt during outbreaks are seen to be of value, but there is also a need for staff at ward level to review routine practice continually so that awareness of activities likely to result in cross-infection is maintained. The use of protective clothing emerges as less important than handwashing, which may be periodically audited to maintain standards.

Entities:  

Mesh:

Year:  1995        PMID: 7704377     DOI: 10.1111/j.1365-2702.1995.tb00004.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  8 in total

1.  Development of a Murine Model with Optimal Routes for Bacterial Infection and Treatment, as Determined with Bioluminescent Imaging in C57BL/6 Mice.

Authors:  Anneke M Brand; Rob Smith; Michele de Kwaadsteniet; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

2.  SCMRSA: a New Approach for Identifying and Analyzing Anti-MRSA Peptides Using Estimated Propensity Scores of Dipeptides.

Authors:  Phasit Charoenkwan; Sakawrat Kanthawong; Nalini Schaduangrat; Pietro Li'; Mohammad Ali Moni; Watshara Shoombuatong
Journal:  ACS Omega       Date:  2022-09-01

Review 3.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

4.  Antimicrobial resistance profile of staphylococcus aureus isolates isolated from ear discharges of patients at University of Hawassa comprehensive specialized hospital.

Authors:  Serawit Deyno; Alemayehu Toma; Mesfin Worku; Muluken Bekele
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-15       Impact factor: 2.483

5.  In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus.

Authors:  Patricia Esteban; Sergio Redrado; Laura Comas; M Pilar Domingo; M Isabel Millán-Lou; Cristina Seral; Sonia Algarate; Concha Lopez; Antonio Rezusta; Julian Pardo; Maykel Arias; Eva M Galvez
Journal:  Toxins (Basel)       Date:  2021-01-23       Impact factor: 4.546

6.  In Vitro Antibacterial, Anti-Adhesive and Anti-Biofilm Activities of Krameria lappacea (Dombey) Burdet & B.B. Simpson Root Extract against Methicillin-Resistant Staphylococcus aureus Strains.

Authors:  Carlo Genovese; Floriana D'Angeli; Francesco Bellia; Alfio Distefano; Mariarita Spampinato; Francesco Attanasio; Daria Nicolosi; Valentina Di Salvatore; Gianna Tempera; Debora Lo Furno; Giuliana Mannino; Fabio Milardo; Giovanni Li Volti
Journal:  Antibiotics (Basel)       Date:  2021-04-13

7.  Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Staphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a Review of the Literature.

Authors:  Seyyed Askhan Senobar Tahaei; Anette Stájer; Ibrahim Barrak; Eszter Ostorházi; Dóra Szabó; Márió Gajdács
Journal:  Infect Drug Resist       Date:  2021-03-23       Impact factor: 4.003

Review 8.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.